Deferred Tax Assets, Valuation Allowance in USD of Baird Medical Investment Holdings Ltd from Q4 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Baird Medical Investment Holdings Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q2 2025.
  • Baird Medical Investment Holdings Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2025 was $825K, a 81.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

Baird Medical Investment Holdings Ltd Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $825K +$369K +81.1% Jun 30, 2025 6-K 2025-12-05
Q4 2024 $775K +$334K +75.6% Dec 31, 2024 6-K 2025-12-05
Q2 2024 $455K Jun 30, 2024 6-K 2025-12-05
Q4 2023 $442K +$35.8K +8.81% Dec 31, 2023 6-K 2025-12-05
Q4 2022 $406K +$76.7K +23.3% Dec 31, 2022 20-F 2025-05-15
Q4 2021 $329K Dec 31, 2021 20-F 2025-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.